Bright Minds Biosciences Inc.

The momentum for this stock is not very good. Bright Minds Biosciences Inc. is not a good growth stock. Bright Minds Biosciences Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Bright Minds Biosciences Inc..
Log in to see more information.

News

Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Up 2.4%
Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Up 2.4%

Ticker Report Bright Minds Biosciences Inc. (NASDAQ:DRUG - Get Free Report) traded up 2.4% on Tuesday . The company traded as high as $1.10 and last traded at $1.09. 22,801 shares traded hands during trading, a...\n more…

DRUG Stock Earnings: Bright Minds Biosciences Reported Results for Q3 2024
DRUG Stock Earnings: Bright Minds Biosciences Reported Results for Q3 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nBright Minds Biosciences just reported results for the third quarter of 2024.\nThe post DRUG Stock Earnings: Bright Minds Biosciences...\n more…

Bright Minds Biosciences (NASDAQ:DRUG) and Avadel Pharmaceuticals (NASDAQ:AVDL) Head to Head Contrast
Bright Minds Biosciences (NASDAQ:DRUG) and Avadel Pharmaceuticals (NASDAQ:AVDL) Head to Head Contrast

Zolmax Avadel Pharmaceuticals (NASDAQ:AVDL - Get Free Report) and Bright Minds Biosciences (NASDAQ:DRUG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will...\n more…

Bright Minds Biosciences (NASDAQ:DRUG) and BeiGene (NASDAQ:BGNE) Financial Comparison
Bright Minds Biosciences (NASDAQ:DRUG) and BeiGene (NASDAQ:BGNE) Financial Comparison

Zolmax Bright Minds Biosciences (NASDAQ:DRUG - Get Free Report) and BeiGene (NASDAQ:BGNE - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two...\n more…

Head to Head Analysis: Bright Minds Biosciences (NASDAQ:DRUG) and BeiGene (NASDAQ:BGNE)
Head to Head Analysis: Bright Minds Biosciences (NASDAQ:DRUG) and BeiGene (NASDAQ:BGNE)

Ticker Report Bright Minds Biosciences (NASDAQ:DRUG - Get Free Report) and BeiGene (NASDAQ:BGNE - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies...\n more…

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Short Interest Update
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Short Interest Update

Ticker Report Bright Minds Biosciences Inc. (NASDAQ:DRUG - Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling...\n more…